Why is Neuland Labs. falling/rising?

As of 29-Oct, Neuland Laboratories Ltd is experiencing a decline in its stock price, currently at Rs 15,374.40, which reflects a decrease of Rs 366.85 or 2.33%. The stock has been underperforming recently, having fallen for six consecutive days, resulting in a total decline of 6.33% during this period. Despite a positive performance over the past month with a 6.61% increase, the stock's current movement contrasts sharply with its recent history, where it has consistently outperformed the BSE500 over the last three years. The stock's ability to service debt remains strong with a low Debt to EBITDA ratio of 0.57 times, and institutional holdings are significant at 34.55%, having increased by 0.89% in the previous quarter, indicating confidence from larger investors.
In the broader market context, the Sensex has shown a positive return of 0.68% over the past week, contrasting with Neuland Laboratories' decline of 5.28% in the same period. This underperformance against the benchmark suggests that the stock is facing specific challenges that are not affecting the overall market. The stock's liquidity appears adequate, with a delivery volume increase of 34.39% against the five-day average, which may indicate rising investor interest despite the recent price drop. Overall, while the stock has shown strong returns over longer periods, its recent performance reflects a combination of short-term selling pressure and market dynamics that are currently unfavorable.